U.S. - Medicaments Containing Hormones But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
Report Update: Feb 1, 2025

U.S. - Medicaments Containing Hormones But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Medicaments Containing Hormones Prices in the United States

U.S. Medicaments Containing Hormones Export Price per Ton in June 2022

In June 2022, the medicaments containing hormones price per ton stood at $565.0K (FOB, US), reducing by -4.5% against the previous month. Over the period under review, the export price, however, showed significant growth. The most prominent rate of growth was recorded in March 2022 when the average export price increased by 125% month-to-month. The export price peaked at $591.6K per ton in May 2022, and then shrank slightly in the following month.

Prices varied noticeably by the country of destination: the country with the highest price was Switzerland ($18.5M per ton), while the average price for exports to Mexico ($1.9K per ton) was amongst the lowest.

From January 2022 to June 2022, the most notable rate of growth in terms of prices was recorded for supplies to Denmark (+151.9%), while the prices for the other major destinations experienced more modest paces of growth.

U.S. Medicaments Containing Hormones Exports

For the third consecutive month, the United States recorded growth in shipments abroad of medicaments containing hormones but not antibiotics, which increased by 226% to 153 tons in July 2022. Overall, exports saw buoyant growth.

In value terms, medicaments containing hormones exports contracted dramatically to $16M (IndexBox estimates) in July 2022. Over the period under review, exports enjoyed a resilient increase. The pace of growth appeared the most rapid in May 2022 with an increase of 191% m-o-m.

U.S. Medicaments Containing Hormones Exports by Country

Mexico (42 tons) was the main destination for medicaments containing hormones exports from the United States, with a 89% share of total exports. Moreover, medicaments containing hormones exports to Mexico exceeded the volume sent to the second major destination, the UK (1.6 tons), more than tenfold. Canada (1.4 tons) ranked third in terms of total exports with a 3% share.

From January 2022 to June 2022, the average monthly growth rate of volume to Mexico stood at +16.8%. Exports to the other major destinations recorded the following average monthly rates of exports growth: the UK (+340.0% per month) and Canada (-2.5% per month).

In value terms, Switzerland ($21M) remains the key foreign market for medicaments containing hormones exports from the United States, comprising 79% of total exports. The second position in the ranking was held by the UK ($500K), with a 1.9% share of total exports. It was followed by Canada, with a 1.3% share.

From January 2022 to June 2022, the average monthly rate of growth in terms of value to Switzerland amounted to +45.8%. Exports to the other major destinations recorded the following average monthly rates of exports growth: the UK (+182.0% per month) and Canada (+5.6% per month).

Source: IndexBox Market Intelligence Platform

This report provides an in-depth analysis of the medicaments containing hormones market in the U.S.. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201250 - Medicaments containing hormones but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale (excluding insulin)

Country coverage:

  • United States

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in the U.S.
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2024
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2024
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. LIST OF TABLES

    1. Key Findings In 2024
    2. Market Volume, In Physical Terms, 2012–2024
    3. Market Value, 2012–2024
    4. Per Capita Consumption In 2012-2024
    5. Imports, In Physical Terms, By Country, 2012–2024
    6. Imports, In Value Terms, By Country, 2012–2024
    7. Import Prices, By Country Of Origin, 2012–2024
    8. Exports, In Physical Terms, By Country, 2012–2024
    9. Exports, In Value Terms, By Country, 2012–2024
    10. Export Prices, By Country Of Destination, 2012–2024
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2024
    2. Market Value, 2012–2024
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2024
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2024
    5. Trade Balance, In Physical Terms, 2012-2024
    6. Trade Balance, In Value Terms, 2012-2024
    7. Per Capita Consumption, 2012-2024
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2024
    22. Production, In Value Terms, 2012–2024
    23. Imports, In Physical Terms, 2012–2024
    24. Imports, In Value Terms, 2012–2024
    25. Imports, In Physical Terms, By Country, 2024
    26. Imports, In Physical Terms, By Country, 2012–2024
    27. Imports, In Value Terms, By Country, 2012–2024
    28. Import Prices, By Country Of Origin, 2012–2024
    29. Exports, In Physical Terms, 2012–2024
    30. Exports, In Value Terms, 2012–2024
    31. Exports, In Physical Terms, By Country, 2024
    32. Exports, In Physical Terms, By Country, 2012–2024
    33. Exports, In Value Terms, By Country, 2012–2024
    34. Export Prices, By Country Of Destination, 2012–2024
Store
Blog
Event
U.S. - Medicaments Containing Hormones But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
$599
Feb 1, 2025
Eye 284

This report provides an in-depth analysis of the medicaments containing hormones market in the U.S..

U.S. - Other Medicaments For Therapeutic Or Prophylactic Uses - Market Analysis, Forecast, Size, Trends And Insights
$599
Feb 1, 2025
Eye 207

This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in the U.S..

U.S. - Medicaments Of Alkaloids Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
$599
Feb 1, 2025
Eye 124

This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in the U.S..

U.S. - Medicaments Of Other Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
$599
Feb 1, 2025
Eye 116

This report provides an in-depth analysis of the market for medicaments of other antibiotics in the U.S..

U.S. - Medicaments Containing Insulin But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
$599
Feb 1, 2025
Eye 300

This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..

U.S. - Medicaments Containing Penicillins Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
$599
Feb 1, 2025
Eye 306

This report provides an in-depth analysis of the medicaments containing penicillin market in the U.S..

World - Medicaments Containing Hormones But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
$599
Feb 1, 2025
Eye 349

This report provides an in-depth analysis of the global medicaments containing hormones market.

World - Other Medicaments For Therapeutic Or Prophylactic Uses - Market Analysis, Forecast, Size, Trends And Insights
$599
Feb 1, 2025
Eye 221

This report provides an in-depth analysis of the global market for other medicaments for therapeutic or prophylactic uses.

World - Medicaments Of Alkaloids Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
$599
Feb 1, 2025
Eye 297

This report provides an in-depth analysis of the global market for medicaments of alkaloids or derivatives thereof.

World - Medicaments Of Other Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
$599
Feb 1, 2025
Eye 174

This report provides an in-depth analysis of the global market for medicaments of other antibiotics.

Eli Lilly Exceeds Earnings Expectations, Ups 2025 Guidance
Feb 6, 2025
Eye 60

Eli Lilly reports strong Q4 2024 earnings, boosts 2025 guidance; driven by impressive GLP-1 drug sales, it remains an attractive investment opportunity.

Exploring the World's Leading Import Markets for Medicaments Containing Hormones
Sep 3, 2024
Eye 119

Discover the top import markets for medicaments containing hormones, including Belgium, Denmark, United States, and more. Learn about the key players in the global market for hormone medications.

The Largest Import Markets for Non-Antibiotic Medicaments
Apr 22, 2024
Eye 260

Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.

Best Import Markets for Non-Penicillin or Streptomycin Antibiotic Medicaments
Jul 16, 2024
Eye 180

Discover the top countries by import value of non-penicillin or streptomycin antibiotic medicaments in 2023. Explore key statistics and market insights.

Pharmaceutical Giants Compete in Obesity Drug Market
Dec 23, 2024
Eye 220

Pharmaceutical companies are fiercely competing in the obesity drug market, with Eli Lilly and Novo Nordisk among the major players. Innovations and collaborations are key in this dynamic and lucrative sector.

Novo Holdings to Finalize $16.5 Billion Acquisition of Catalent
Dec 14, 2024
Eye 168

Novo Holdings finalizes $16.5 billion acquisition of Catalent, enhancing pharmaceutical capabilities amidst regulatory clearance.

Eli Lilly Exceeds Earnings Expectations, Ups 2025 Guidance
Feb 6, 2025
Eye 60

Eli Lilly reports strong Q4 2024 earnings, boosts 2025 guidance; driven by impressive GLP-1 drug sales, it remains an attractive investment opportunity.

Exploring the World's Leading Import Markets for Medicaments Containing Hormones
Sep 3, 2024
Eye 119

Discover the top import markets for medicaments containing hormones, including Belgium, Denmark, United States, and more. Learn about the key players in the global market for hormone medications.

The Largest Import Markets for Non-Antibiotic Medicaments
Apr 22, 2024
Eye 260

Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.

Best Import Markets for Non-Penicillin or Streptomycin Antibiotic Medicaments
Jul 16, 2024
Eye 180

Discover the top countries by import value of non-penicillin or streptomycin antibiotic medicaments in 2023. Explore key statistics and market insights.

Free Data: Medicaments Containing Hormones But Not Antibiotics - United States